Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board

Press
May 6, 2021
Endpoints News
TOC LINK
TOC LINK
Press
Published 
May 6, 2021

More like this

Dyno Therapeutics Launches Three Breakthrough Capsid Delivery Vectors for Next-Generation Eye, Muscle and CNS Gene Therapies at the 2025 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Announcements
Dyno Therapeutics
May 14, 2025

Dyno Therapeutics Launches Three Breakthrough Capsid Delivery Vectors for Next-Generation Eye, Muscle and CNS Gene Therapies at the 2025 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Announcements
Dyno Therapeutics
May 14, 2025

Dyno Therapeutics Announces Inaugural 2025 Genetic Agency Technology Conference and Launch of Dyno Frontiers Program to Accelerate Progress in Patient-Empowering Gene Therapies

Announcements
Dyno Therapeutics
May 14, 2025

Dyno Therapeutics Announces Inaugural 2025 Genetic Agency Technology Conference and Launch of Dyno Frontiers Program to Accelerate Progress in Patient-Empowering Gene Therapies

Announcements
Dyno Therapeutics
May 14, 2025

Astellas and Dyno Therapeutics Announce Research Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle

Announcements
December 2, 2021

Astellas and Dyno Therapeutics Announce Research Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle

Announcements
December 2, 2021

Sarepta Therapeutics and Dyno Therapeutics Announce Agreement to Develop Next-Generation Gene Therapy Vectors for Muscle Diseases

Announcements
May 11, 2020

Sarepta Therapeutics and Dyno Therapeutics Announce Agreement to Develop Next-Generation Gene Therapy Vectors for Muscle Diseases

Announcements
May 11, 2020
343 Arsenal St
Watertown, MA 02472
© Dyno 2026
Privacy PolicyTerms + Conditions
Dyno Therapeutics, DYNO, the DYNO logo, and mountain design are registered trademarks of Dyno Therapeutics, Inc. All rights reserved.